PARP1 inhibitors and uses thereof
Compounds selectively inhibiting PARP1 address the need for improved PARP inhibitors by enhancing cancer treatment efficacy and reducing toxicity in HRD and BRCA1/2 mutation cancers, including multiple cancer types.
AU2023213731B2Pending Publication Date: 2026-07-09XINTHERA INC
Patent Information
- Authority / Receiving Office
- AU · AU
- Patent Type
- Applications
- Current Assignee / Owner
- XINTHERA INC
- Filing Date
- 2023-01-26
- Publication Date
- 2026-07-09
Abstract
Described herein are PARP1 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of cancer.
Need to check novelty before this filing date? Find Prior Art